CN Stock MarketDetailed Quotes
300149 ChemPartner PharmaTech
- 6.94
- +0.86+14.14%
Market Closed Sep 30 15:00 CST
3.47BMarket Cap-3654P/E (TTM)
7.05High6.05Low809.50KlotVolume6.19Open6.08Pre Close527.23MTurnover16.23%Turnover RatioLossP/E (Static)499.78MShares9.3052wk High2.48P/B3.46BFloat Cap3.6852wk Low7.30Limit Up498.90MShs Float28.27Historical High4.86Limit Down16.45%Amplitude2.25Historical Low--Dividend TTM6.51Avg Price361.38KlotAsk--Div YieldTTM100Lot Size409.71KlotBid
ChemPartner PharmaTech Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -16.56%465.16M | -12.68%234.59M | -14.19%1.14B | -18.02%846.18M | -18.84%557.45M | -30.45%268.66M | -21.54%1.33B | -18.17%1.03B | -18.75%686.9M | -0.87%386.3M |
| Operating revenue | -16.56%465.16M | -12.68%234.59M | -14.19%1.14B | -18.02%846.18M | -18.84%557.45M | -30.45%268.66M | -21.54%1.33B | -18.17%1.03B | -18.75%686.9M | -0.87%386.3M |
| Other operating revenue | -16.47%2.45M | ---- | 17.26%6.5M | ---- | -60.89%2.93M | ---- | -9.98%5.54M | ---- | 158.66%7.5M | ---- |
| Total operating cost | -9.72%525.1M | -13.25%263.46M | -14.01%1.21B | -10.58%889.62M | -18.46%581.64M | -17.69%303.71M | -17.08%1.41B | -21.11%994.88M | -15.83%713.3M | -6.38%368.98M |
| Operating cost | -8.49%389.33M | -1.31%193.14M | -13.44%856.34M | -2.21%645.74M | -5.45%425.44M | -16.16%195.7M | -14.34%989.33M | -24.07%660.31M | -25.16%449.95M | -15.34%233.43M |
| Operating tax surcharges | 12.85%3.14M | 250.94%970.46K | -24.22%5.67M | -56.69%3.09M | -34.24%2.78M | -73.94%276.53K | 31.57%7.48M | 116.86%7.14M | 95.22%4.23M | 1.02%1.06M |
| Operating expense | -2.87%21.08M | 7.95%11M | -26.27%45.6M | -29.35%33.63M | -40.73%21.7M | -44.00%10.19M | -2.72%61.85M | 7.43%47.6M | 27.86%36.62M | 5.12%18.19M |
| Administration expense | -17.41%77.68M | -34.66%39.21M | -13.70%212.55M | -34.70%142.86M | -35.43%94.05M | -11.55%60M | -8.13%246.3M | 13.15%218.79M | 25.34%145.67M | 22.84%67.84M |
| Financial expense | 396.09%1.71M | -86.42%2.25M | 18.71%14.02M | 128.26%5.44M | -98.22%343.82K | -17.33%16.58M | -85.65%11.81M | -132.36%-19.24M | -52.42%19.36M | 0.21%20.06M |
| -Interest expense (Financial expense) | -36.71%2.14M | -59.31%1.06M | -52.92%31.3M | -83.06%4.29M | -83.61%3.38M | -77.56%2.61M | -15.56%66.48M | -33.29%25.3M | -48.04%20.63M | -6.28%11.63M |
| -Interest Income (Financial expense) | 46.16%-4.66M | 67.76%-2.28M | -25.22%-14.79M | -86.29%-11.41M | -1,328.37%-8.66M | -2,653.92%-7.07M | -216.89%-11.81M | -134.79%-6.12M | 64.39%-606.54K | 68.92%-256.68K |
| Research and development | -13.81%32.17M | -19.33%16.9M | -16.05%77.47M | -26.69%58.85M | -35.06%37.32M | -26.22%20.95M | -25.97%92.28M | -11.77%80.28M | -1.80%57.47M | 14.48%28.4M |
| Credit Impairment Loss | -284.46%-11.88M | 161.38%272.3K | 69.63%-6.07M | 57.21%-1.35M | 45.74%-3.09M | 92.89%-443.59K | -794.19%-20M | -366.06%-3.16M | -2,226.40%-5.69M | -137.96%-6.24M |
| Asset Impairment Loss | -21.17%-3.38M | -27.12%-1.94M | -60.25%-855.85M | -48.33%-2.84M | 12.26%-2.79M | 5.80%-1.52M | -43.77%-534.07M | 36.81%-1.92M | 25.12%-3.18M | 9.41%-1.62M |
| Other net revenue | -271.80%-9.73M | -50.27%1.6M | -200.98%-854.27M | -99.36%8.75M | -99.58%5.67M | 154.83%3.22M | 343.91%845.95M | 10,582.62%1.36B | 40,370.30%1.35B | -573.26%-5.87M |
| Fair value change income | --0 | ---- | --0 | -756.37%-364.95K | -484.80%-249.22K | ---- | -167.79%-42.62K | ---42.62K | ---42.62K | ---42.62K |
| Invest income | -69.61%2.5M | -47.35%1.73M | -100.07%-922.4K | -99.25%10.26M | -99.39%8.23M | 645.26%3.28M | 12,557.71%1.39B | 27,953.66%1.36B | 30,542.64%1.36B | -89.80%440.24K |
| Net open hedge income | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Investment income associates | -69.65%2.35M | -44.69%1.72M | -382.83%-1.53M | 18.48%9.7M | 48.92%7.76M | 751.89%3.11M | -2,054.88%-317.14K | 94.07%8.19M | 29.76%5.21M | -91.19%364.8K |
| Asset deal income | 454.27%48.13K | ---- | 99.73%-412.39 | -371.17%-1.55M | 93.38%-13.59K | ---- | -615.27%-154.77K | -4,368.88%-328.12K | -2,694.95%-205.21K | ---28.93K |
| Other revenue | -16.84%2.98M | -19.25%1.54M | -6.55%8.57M | -34.23%4.59M | 14.46%3.58M | 17.44%1.9M | -42.20%9.17M | -28.40%6.98M | 7.86%3.13M | 21.60%1.62M |
| Operating profit | -276.25%-69.67M | 14.33%-27.27M | -221.49%-927.55M | -102.48%-34.69M | -101.40%-18.52M | -378.01%-31.83M | 314.82%763.48M | 10,537.68%1.4B | 106,159.01%1.32B | 458.93%11.45M |
| Add:Non operating Income | -91.00%20.15K | -44.20%67.99K | 159.75%815.88K | 86.91%319.05K | 82.61%224.04K | 127.68%121.85K | -30.82%314.1K | -52.30%170.7K | -56.29%122.68K | 30,499.67%53.52K |
| Less:Non operating expense | 571.32%405.33K | 75,397.43%239.55K | -77.89%4.22M | -89.53%65.62K | -83.35%60.38K | -99.37%317.3 | 213.71%19.08M | -32.50%626.76K | -59.72%362.71K | -90.21%50.56K |
| Total profit | -281.70%-70.06M | 13.46%-27.44M | -225.01%-930.96M | -102.46%-34.44M | -101.39%-18.35M | -376.88%-31.71M | 306.28%744.72M | 11,016.81%1.4B | 211,304.46%1.32B | 409.01%11.45M |
| Less:Income tax cost | -302.71%-7.08M | 37.67%-1.94M | -106.23%-22.83M | -98.16%6.91M | -99.05%3.49M | -252.94%-3.11M | 792.07%366.34M | 17,782.01%374.87M | 8,512.22%367.22M | 138.41%2.04M |
| Net profit | FPtoL-62.98M | FPtoL-25.5M | SL-908.13M | SL-41.35M | SL-21.85M | SL-28.6M | FLtoP378.38M | 6,862.37%1.02B | 19,063.16%956.54M | 491.00%9.42M |
| Net profit from continuing operation | -188.30%-62.98M | 10.83%-25.5M | -340.01%-908.13M | -104.04%-41.35M | -102.28%-21.85M | -403.67%-28.6M | 194.10%378.38M | 6,862.37%1.02B | 19,063.16%956.54M | 491.00%9.42M |
| Less:Minority Profit | -6.27%-73.71K | -36.66%-39.2K | 10.00%-186.3K | 11.10%-145.68K | -47.02%-69.36K | 47.13%-28.68K | -239.56%-206.99K | -19.95%-163.88K | 67.76%-47.18K | -41.23%-54.25K |
| Net profit of parent company owners | -188.88%-62.91M | 10.87%-25.46M | -339.83%-907.94M | -104.03%-41.2M | -102.28%-21.78M | -401.63%-28.57M | 194.12%378.59M | 6,799.35%1.02B | 18,518.34%956.58M | 480.41%9.47M |
| Earning per share | ||||||||||
| Basic earning per share | -215.75%-0.1263 | 11.32%-0.0509 | -339.47%-1.82 | -104.03%-0.0827 | -102.08%-0.04 | -402.11%-0.0574 | 193.83%0.76 | 6,793.29%2.0542 | 18,540.78%1.92 | 533.33%0.019 |
| Diluted earning per share | -215.75%-0.1263 | 11.32%-0.0509 | -339.47%-1.82 | -104.03%-0.0827 | -102.08%-0.04 | -402.11%-0.0574 | 193.83%0.76 | 6,793.29%2.0542 | 18,540.78%1.92 | 533.33%0.019 |
| Other composite income | -111.70%-1.14M | 134.65%1.88M | -66.81%7.82M | -65.76%10M | -17.16%9.79M | -530.58%-5.41M | 507.32%23.57M | 4,446.97%29.22M | 718.75%11.81M | 75.94%-858.64K |
| Other composite income of parent company owners | -111.70%-1.14M | 134.65%1.88M | -66.81%7.82M | -65.76%10M | -17.16%9.79M | -530.58%-5.41M | 507.32%23.57M | 4,446.97%29.22M | 718.75%11.81M | 75.94%-858.64K |
| Total composite income | -431.74%-64.13M | 30.54%-23.62M | -323.99%-900.31M | -102.98%-31.35M | -101.25%-12.06M | -497.40%-34.01M | 198.54%401.95M | 7,404.34%1.05B | 31,316.11%968.35M | 533.11%8.56M |
| Total composite income of parent company owners | -434.20%-64.05M | 30.60%-23.58M | -323.82%-900.12M | -102.96%-31.2M | -101.24%-11.99M | -494.57%-33.98M | 198.56%402.15M | 7,333.10%1.05B | 29,893.84%968.4M | 544.50%8.61M |
| Total composite income of minority owners | -6.27%-73.71K | -36.66%-39.2K | 10.00%-186.3K | 11.10%-145.68K | -47.02%-69.36K | 47.13%-28.68K | -239.56%-206.99K | -19.95%-163.88K | 67.76%-47.18K | -41.23%-54.25K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data